Skip to main content
NCBI home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1988 Jun;26(3):263–268. doi: 10.1007/BF00199939

Differential sensitivity to natural cell-mediated cytotoxicity of two rat colon adenocarcinoma variants differing in their tumorigenicity: identification of the effector cells as natural killer cells

Hélène Pelletier 1,✉, Nils-Olivier Olsson 1, Catherine Fady 1, Danièle Reisser 1, Patricia Lagadec 1, Jean-François Jeannin 1
PMCID: PMC11038652  PMID: 3383206

Abstract

DHD/K12 TRb (PROb) and DHD/K12 TSb (REGb) are two cancer cell variants originating from the same rat colon adenocarcinoma. They differ in their tumorigenicity: when inoculated into syngeneic BDIX rats, PROb cells induce progressive tumors whereas REGb cells induce tumors which always regress. As previously described, there is an inverse relation between their tumorigenicity and their susceptibility to NCMC mediated by syngeneic spleen or peripheral blood lymphocytes: PROb cells are significantly less sensitive to NCMC than REGb cells. This suggests a role for NCMC in the regression of REGb tumors. In this work the BDIX NCMC effector cells active in vitro against REGb cells were identified as NK cells according to four criteria: (1) efficacy in a 4-h 51Cr release assay, (2) sensitivity to anti-asGM1 antibody plus complement, (3) LGL morphology, and (4) ability to bind with the same affinity REGb and YAC-1 cells. In spleen, these NK cells were heterogeneous with respect to their asGM1 surface density and their morphology. PROb cells were not lysed by these NK cells in a short-term cytotoxicity assay, but only in a 16-h assay. It was shown that PROb and REGb cells were bound with the same affinity by NK cells, thus they certainly differ in their ability to resist to NK lytic mechanisms. This difference could play a role in the different tumorigenicity of the two variants.

Keywords: Natural Killer, Natural Killer Cell, Effector Cell, Peripheral Blood Lymphocyte, Colon Adenocarcinoma

Footnotes

Abbreviations used: NK, natural killer; NC, natural cytotoxic; NCMC, natural cell-mediated cytotoxicity; asGM1, asialo GM1; LL, large lymphocytes; LGL, large grnular lymphocytes; LAL, large agranular lymphocytes; PBMNC, peripheral blood mononuclear cells; E:T, effector to target cell ratio; C:H, cold to hot cell ratio; FBS, fetal bovine serum

References

  • 1.Caignard A, Martin MS, Michel MF, Martin F. Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host. Int J Cancer. 1985;36:273. doi: 10.1002/ijc.2910360221. [DOI] [PubMed] [Google Scholar]
  • 2.Chen TR. In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res. 1977;104:255. doi: 10.1016/0014-4827(77)90089-1. [DOI] [PubMed] [Google Scholar]
  • 3.Cikes M, Friberg S, Klein G. Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by Moloney leukemia virus in cultured murine lymphomas. J Natl Cancer Inst. 1973;50:347. doi: 10.1093/jnci/50.2.347. [DOI] [PubMed] [Google Scholar]
  • 4.Futami H, Saijo N, Sasaki Y, Sakurai M, Nomori H, Takahashi H, Ishihara J, Hoshi A, Koyama K, Hamburger AW, Jett JR. Differences of host immune response and of sensitivity to chemotherapeutic agents between two clones of rat fibrosarcoma with different metastatic potential. Jpn J Cancer Res. 1986;77:480. [PubMed] [Google Scholar]
  • 5.Gorelik E, Herberman RB. Radioisotope assay for evaluation of in vivo natural cell-mediated resistance of mice to local transplantation of tumor cells. Int J Cancer. 1981;27:709. doi: 10.1002/ijc.2910270519. [DOI] [PubMed] [Google Scholar]
  • 6.Hanna N, Fidler IJ. Relationship between metastatic potential and resistance to natural killer cell-mediated cytotoxicity in three murine tumor systems. J Natl Cancer Inst. 1981;66:1183. [Google Scholar]
  • 7.Hanna N. Immunobiology of natural killer cells vol 2. Boca Raton: CRC Press; 1986. In vivo activities of NK cells against primary and metastatic tumors in experimental animals; p. 1. [Google Scholar]
  • 8.Herberman RB, Holden HT. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
  • 9.Herberman RB, Ortaldo JR. Natural killer cells: their role in defenses against disease. Science. 1981;214:24. doi: 10.1126/science.7025208. [DOI] [PubMed] [Google Scholar]
  • 10.Herberman RB, Aoki T, Nunn N, Lavrin DH, Soares N, Gazdar A, Holden H, Chang KSS. Specificity of 51Cr release cytotoxicity by lymphocytes immune to murine sarcoma virus. J Natl Cancer Inst. 1974;53:1103. doi: 10.1093/jnci/53.4.1103. [DOI] [PubMed] [Google Scholar]
  • 11.Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer. 1975;16:216. doi: 10.1002/ijc.2910160204. [DOI] [PubMed] [Google Scholar]
  • 12.Herberman RB, Djeu JY, Kay HD, Ortaldo JR, Riccardi C, Bonnard GD, Holden HT, Fagnani R, Santoni A, Pucceti P. Natural killer cells: characteristics and regulation of activity. Immunol Rev. 1979;44:43. doi: 10.1111/j.1600-065x.1979.tb00267.x. [DOI] [PubMed] [Google Scholar]
  • 13.Itoh K, Suzuki R, Umezu Y, Hanaumi K, Kumagai K. Studies of murine large granular lymphocytes. II. Tissue, strain and age distributions of LGL and LAL. J Immunol. 1982;129:395. [PubMed] [Google Scholar]
  • 14.Kasai M, Iwamori M, Nagai Y, Okumura K, Tada T. A glycolipid on the surface of mouse natural killer cells. Eur J Immunol. 1980;10:175. doi: 10.1002/eji.1830100304. [DOI] [PubMed] [Google Scholar]
  • 15.Kawase I, Urdal DL, Brooks CG, Henney CS. Selective depletion of NK cells activity in vivo and its effect on the growth of NK-sensitive and NK-resistant tumor cell variants. Int J Cancer. 1982;29:567. doi: 10.1002/ijc.2910290513. [DOI] [PubMed] [Google Scholar]
  • 16.Kiessling R, Wigzell H. An analysis of the murine NK cells as to structure, function and biological relevance. Immunol Rev. 1979;44:165. doi: 10.1111/j.1600-065x.1979.tb00270.x. [DOI] [PubMed] [Google Scholar]
  • 17.Korec S, Herberman RB, Dean JH, Cannon GB. Cytostasis of tumor cell lines by human granulocytes. Cell Immunol. 1980;53:104. doi: 10.1016/0008-8749(80)90430-x. [DOI] [PubMed] [Google Scholar]
  • 18.Kumagai K, Itoh K, Suzuki R, Hinuma S, Saitoh F. Studies of murine large granular lymphocytes. I. Identification as effector cells in NK and K cytotoxicities. J Immunol. 1982;129:388. [PubMed] [Google Scholar]
  • 19.Kunkel LA, Welsh RM. Metabolic inhibitors render “resistant” target cells sensitive to natural killer cell-mediated lysis. Int J Cancer. 1981;27:73. doi: 10.1002/ijc.2910270112. [DOI] [PubMed] [Google Scholar]
  • 20.Laybourn KA, Kiserodt JC, Abruzzo LV, Varani J. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells. Cancer Res. 1986;46:3407. [PubMed] [Google Scholar]
  • 21.Lin Y, Patek PQ, Collins JL, Cohn M. Analysis of immune surveillance of sequentially derived cell lines that differ in their tumorigenic potential. J Natl Cancer Inst. 1985;74:1025. [PubMed] [Google Scholar]
  • 22.Mantovani A. Natural cytotoxicity on tumor cells of human macrophages obtained from diverse anatomical sites. Clin Exp Immunol. 1980;39:776. [PMC free article] [PubMed] [Google Scholar]
  • 23.Martin F, Knobel S, Martin M, Bordes M. A carcinofetal antigen located on the membrane of cells from rat intestinal carcinoma in culture. Cancer Res. 1975;35:333. [PubMed] [Google Scholar]
  • 24.Martin F, Caignard A, Jeannin JF, Leclerc A, Martin M. Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int J Cancer. 1983;32:623. doi: 10.1002/ijc.2910320517. [DOI] [PubMed] [Google Scholar]
  • 25.Oehler JR, Lindsay LR, Nunn ME, Herberman RB. Natural cell mediated cytotoxicity in rats. I. Tissue and strain distribution and demonstration of a membrane receptor for the Fc portion of IgG. Int J Cancer. 1978;21:204. doi: 10.1002/ijc.2910210212. [DOI] [PubMed] [Google Scholar]
  • 26.Ortaldo JR, Herberman RB. Heterogeneity of natural killer cells. Ann Rev Immunol. 1984;2:359. doi: 10.1146/annurev.iy.02.040184.002043. [DOI] [PubMed] [Google Scholar]
  • 27.Patek PQ, Lin Y, Collins JL, Cohn M. In vivo or in vitro selection for resistance to natural cytotoxic cell lysis selects for variants with increased tumorigenicity. J Immunol. 1986;136:741. [PubMed] [Google Scholar]
  • 28.Pelletier H, Olsson NO, Shimizu T, Lagadec P, Fady C, Reisser D, Jeannin JF. In vitro natural killer activity against progressive and regressive variants of a rat colon adenocarcinoma. Effect of treatments with anti-asialo GM1 plus complement. Immunobiology. 1987;175:202. doi: 10.1016/S0171-2985(87)80029-3. [DOI] [PubMed] [Google Scholar]
  • 29.Reynolds CW, Timonen T, Herberman RB. Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells. J Immunol. 1981;127:282. [PubMed] [Google Scholar]
  • 30.Reynolds CW, Sharrow SO, Ortaldo JR, Herberman RB. Natural killer activity in the rat. II. Analysis of surface antigens on LGL by flow cytometry. J Immunol. 1981;127:2204. [PubMed] [Google Scholar]
  • 31.Riccardi C, Santoni A, Barlozzari T, Pucceti P, Herberman RB. In vivo natural reactivity of mice against tumor cells. Int J Cancer. 1980;25:475. doi: 10.1002/ijc.2910250409. [DOI] [PubMed] [Google Scholar]
  • 32.Shimizu T, Pelletier H, Hammann A, Olsson NO, Martin MS, Martin F. Effects of a single injection of anti-asialo GM1 serum on natural cytotoxicity and the growth of a regressive colonic tumor in syngeneic rats. Int J Cancer. 1987;40:676. doi: 10.1002/ijc.2910400518. [DOI] [PubMed] [Google Scholar]
  • 33.Stutman O, Paige CJ, Figarella EF. Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility. J Immunol. 1978;121:1819. [PubMed] [Google Scholar]
  • 34.Tang J, Delong DC, Marder P, Butler LD, Ades EW. Identification of functional subpopulations of murine natural killer cells based on their cell surface asialo GM1 phenotype. Cell Immunol. 1985;96:386. doi: 10.1016/0008-8749(85)90369-7. [DOI] [PubMed] [Google Scholar]
  • 35.Timonen T, Saksela E. Isolation of human natural killer cells by discontinuous gradient centrifugation. J Immunol Methods. 1980;36:285. doi: 10.1016/0022-1759(80)90133-7. [DOI] [PubMed] [Google Scholar]
  • 36.Timonen T, Reynolds CW, Ortaldo JR, Herberman RB. Isolation of human and rat natural killer cells. J Immunol Methods. 1982;41:269. doi: 10.1016/0022-1759(82)90393-3. [DOI] [PubMed] [Google Scholar]
  • 37.Ting CC, Hargrove ME, Wunderlich J, Loh NN. Differential expression of asialo GM1 on alloreactive cytotoxic T lymphocytes and lymphokine-activated killer cells. Cell Immunol. 1987;104:115. doi: 10.1016/0008-8749(87)90012-8. [DOI] [PubMed] [Google Scholar]
  • 38.Yoshioka T, Sato S, Fujiwara H, Hamaoka T. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo. Jpn J Cancer Res. 1986;77:825. [PubMed] [Google Scholar]
  • 39.Young WW, Hakomori SI, Durdik JM, Henney CS. Identification of ganglio-N-tetraosylceramide as a new cell surface marker for murine natural killer (NK) cells. J Immunol. 1980;124:199. [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES